EUVIMEDEUVIMED entdecken
Crossref

Exosomatic miR‐1246 Promotes Hepatocellular Carcinoma Progression via FSTL5 and ERK/p38 MAPK Pathway

Wen-Ju Chen, Ying-Jie Dai, Wan-Hong Gu, Chun-Ling Zhang, Yi-Chao Wang

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Wen-Ju Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, Exosomes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: This study was supported by Zhejiang Provincial Medicine and Health Science and Technology Project (2019KY243)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. Unfortunately, the effective targeted therapies for HCC are lacking at present. While the regulation of microRNA‐1246 (miR‐1246) has been identified in HCC, its specific mechanism in exosomes derived from HCC remains elusive. This study aimed to explore the regulation of tumor‐derived exosome miR‐1246 in HCC cell invasion, migration, proliferation, and epithelial‐mesenchymal transition (EMT).

Methods

Exosomes secreted by HepG2 cells were characterized via Western blotting, nanoparticle tracking analysis, and transmission electron microscopy, followed by transfection with a miR‐1246 inhibitor. RT‐qPCR was employed for measuring the miR‐1246 levels. Also, the impacts of the exosome miR‐1246 inhibitor on HepG2 cell migration, invasion, proliferation, and EMT were evaluated.

Results

The findings revealed elevated miR‐1246 levels in HCC tissues relative to adjacent non‐cancerous tissues, with a greater enrichment of miR‐1246 in HepG2‐derived exosomes than in HepG2 cells. HCC cell invasion, migration, proliferation, and EMT were significantly enhanced by HCC‐derived exosomes, while exosomes loaded with miR‐1246 inhibitor inhibited these biological functions. Further mechanistic studies illustrated an association of the regulatory role of miR‐1246 with FSTL5 and ERK/p38 MAPK signaling.

Conclusion

In conclusion, tumor‐derived miR‐1246 enters hepatocellular carcinoma cells in the form of exosomes and promotes cancer cell invasion, EMT, and migration. The potential mechanism of miR‐1246 is potentially relevant to the targeted gene FSTL5 as well as the ERK/p38 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsExosomesp38 Mitogen-Activated Protein KinasesMAP Kinase Signaling SystemDisease ProgressionRNA, NeoplasmHumansHep G2 CellsCell MovementCell ProliferationEpithelial-Mesenchymal TransitionNeoplasm Invasiveness

Stichwörter der Autor:innen

ERK/p38 MAPK signalingFSTL5cell proliferationepithelial‐mesenchymal transition (EMT)exosomehepatocellular carcinomamiR‐1246tumor invasion and migration

Substanzen

MicroRNAsMIRN1246 microRNA, humanp38 Mitogen-Activated Protein KinasesRNA, Neoplasm

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.

Förderung

  • This study was supported by Zhejiang Provincial Medicine and Health Science and Technology Project (2019KY243).

Zitieren

APA

Chen, W. J., Dai, Y. J., Gu, W. H., Zhang, C. L., & Wang, Y. C. (2025). Exosomatic miR‐1246 Promotes Hepatocellular Carcinoma Progression via FSTL5 and ERK/p38 MAPK Pathway. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70148

Vancouver

Chen WJ, Dai YJ, Gu WH, Zhang CL, Wang YC. Exosomatic miR‐1246 Promotes Hepatocellular Carcinoma Progression via FSTL5 and ERK/p38 MAPK Pathway. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70148

BibTeX
@article{Chen2025,
  author = {Chen, Wen-Ju and Dai, Ying-Jie and Gu, Wan-Hong and Zhang, Chun-Ling and Wang, Yi-Chao},
  title = {Exosomatic miR‐1246 Promotes Hepatocellular Carcinoma Progression via FSTL5 and ERK/p38 MAPK Pathway},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70148}
}
Kostenlos starten →